Objective:

To explore the benefits and drawbacks of private equity versus private practice models in ophthalmology, highlighting their significance in the evolving healthcare landscape.

Key Findings:

• In 2024, only 42.2% of U.S. physicians were in private practice, down from 60% in 2012, indicating a significant shift in practice models.
• Ophthalmology has a higher independence rate at 70.4%, but has seen 245 practices acquired by private equity from 2012 to 2021, raising questions about the future of independent practice.
• Private equity offers operational support, allowing physicians to focus more on patient care, but may compromise autonomy and affect the quality of patient interactions.

Interpretation:

The choice between private equity and private practice involves trade-offs between autonomy and efficiency, significantly impacting physician satisfaction and patient care quality.

Limitations:

• The article does not provide quantitative data on patient outcomes related to each practice model, limiting the assessment of their effectiveness.
• Perspectives are based on subjective experiences of physicians, which may not represent the broader population and could introduce bias.

Conclusion:

The decision between private equity and private practice is complex, influenced by personal values, financial goals, and the evolving healthcare landscape, underscoring the need for informed decision-making.